China's Hisun shifts gear to hi-tech and branded in alliances with Enzon and Celsion
This article was originally published in Scrip
Executive Summary
Some Chinese pharma companies are apparently no longer satisfied with just manufacturing low-end drugs like generic antibiotics. With more money in hand and an expanding high-quality domestic talent pool, a growing number are eyeing more lucrative fields such as oncology.